Ledger.Open graph →
SEC Form D · Amendment · filed October 16, 2013

BELLICUM PHARMACEUTICALS, INC

Offering
$35.0M
Sold
$19.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
HOUSTON, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

James F. Brown · Walnut Creek, CADirectorDennis K. Stone · Dallas, TXDirectorThomas J. Farrell · Houston, TXExec · DirectorWilliam J. Scott · St Peter Port, Y7DirectorMatthew Cowan · Menlo Park, CADirectorThomas J. Farrell · San Diego, CAExec · DirectorKevin M. Slawin · Houston, TXExec · DirectorFrank Mcguyer · Houston, TXDirectorDavid M. Spencer · Houston, TXExecAnnemarie Moseley · Houston, TXExecJoseph Senesac · Houston, TXExecKen Moseley · Houston, TXExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗